Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04332172 · ClinicalTrials.gov registry record · NA

Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy

A NA study, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
384
Enrollment target

NCT04332172: Completed NA study, sponsored by Michigan State University.

NCT04332172 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 384 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04332172, a NA study, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
384 participants
Enrollment target

Study Summary

The purpose of this research study is to find out if pregnant women screening positive for alcohol risk like the brief alcohol intervention application that the investigators have developed (called the MommyCheckup, which is a technology-delivered SBIRT, or e-SBIRT), and if it helps them to reduce alcohol use. The investigators also wish to test whether e-SBIRT effects can be enhanced by booster sessions and/or tailored text messages.

Primary Outcome

The primary outcome of abstinence will be defined as no self-report of alcohol use in the past 90 days via Timeline FollowBack.

Interventions

  • BEHAVIORAL SMS
  • OTHER General information
  • BEHAVIORAL Baseline brief intervention
  • BEHAVIORAL Remote online booster sessions

Trial Details

FieldValue
Enrollment Target 384 participants
Start Date 2023-05-19
Est. Completion 2025-08-31
Phase NA
Michigan State University

120 total trials

What the finished NCT04332172 record still lists

NCT04332172 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).

The record links to 0 conditions, and to 4 interventions - of which SMS is the first listed.

NCT04332172 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04332172 about?

NCT04332172 is a clinical study titled "Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy". The purpose of this research study is to find out if pregnant women screening positive for alcohol risk like the brief alcohol intervention application that the investigators have developed (called the MommyCheckup, which is a technology-delivered SBIRT, or e-SBIRT), and if it helps them to reduce a...

What is the current status of trial NCT04332172?

This trial is currently completed. It is a NA study. The enrollment target is 384 participants. The study started on 2023-05-19. Estimated completion is 2025-08-31.

What interventions are being tested in trial NCT04332172?

The interventions under investigation include: SMS (BEHAVIORAL), General information (OTHER), Baseline brief intervention (BEHAVIORAL), Remote online booster sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT04332172?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04332172's enrollment target sits among peer trials

384 271st of 2000 higher than 1,728 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06277661 · 384 participants · NA

    The Mom and Infant Outcomes (MOMI) Study

  • NCT06372964 · 384 participants · Phase 3

    Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • NCT06501040 · 384 participants · NA

    Increasing Knowledge and Interest in Cancer Clinical Trials

  • NCT06566703 · 384 participants · NA

    Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04332172, the US trial registry maintained by the National Library of Medicine. NCT04332172 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.